| Literature DB >> 31189380 |
Frauke Hennig1, Susanne Moebus2, Nico Reinsch3,4, Thomas Budde3, Raimund Erbel2, Karl-Heinz Jöckel2, Nils Lehmann2, Barbara Hoffmann1, Hagen Kälsch3,4.
Abstract
AIMS: Air pollution and noise are potential risk factors for subclinical atherosclerosis. Longitudinal analyses, especially on the interplay of these environmental factors, are scarce and inconsistent. Hence we investigated long-term traffic-related exposure to air pollution and noise with the development and progression of thoracic aortic calcification, a marker of subclinical atherosclerosis.Entities:
Keywords: Atherosclerosis; air pollution; epidemiology; traffic noise
Year: 2019 PMID: 31189380 PMCID: PMC7272124 DOI: 10.1177/2047487319854818
Source DB: PubMed Journal: Eur J Prev Cardiol ISSN: 2047-4873 Impact factor: 7.804
Baseline characteristics (mean ± SD, N (%)) of the full study sample (n = 3155) and stratified in subgroups of TACt0 < 10 (n = 1433) and TACt0 ≥ 10 (n = 1722).
| Variable | All | TACt0 < 10 | TACt0 ≥ 10 | |
|---|---|---|---|---|
| TAC (t0) (Agatston score)[ | 15.5 (108.4) | 0.0 (0.0) | 90.5 (239.8) | <0.001 |
| TAC (t1) (Agatston score)[ | 28.9 (306.5) | 0.0 (34.5) | 168.1 (743.2) | <0.001 |
| Incident TAC[ | 498 (42.5%) | 498 (42.5%) | ||
| TAC progression | 1672 (53%) | 594 (41.5%) | 1078 (62.6%) | <0.001 |
| TAC growth (rate) | 0.1 ± 0.5 | 0.3 ± 0.5 | –0.1 ± 0.4 | <0.001 |
| Age (years) | 59.1 ± 7.6 | 56.4 ± 7.0 | 61.4 ± 7.4 | <0.001 |
| Sex | 0.001 | |||
| Male | 1490 (47.2%) | 631 (44.0%) | 859 (49.9%) | |
| Female | 1665 (52.8%) | 802 (56.0%) | 863 (50.1%) | |
| Education | 0.003 | |||
| ≤10 years | 302 (9.6%) | 111 (7.7%) | 191 (11.1%) | |
| 11–13 years | 1795 (56.9%) | 820 (57.2%) | 975 (56.6%) | |
| 14–17 years | 701 (22.2%) | 319 (22.3%) | 382 (22.2%) | |
| ≥18 years | 357 (11.3%) | 183 (12.8%) | 174 (10.1%) | |
| Neigbourhood unemploymentrate (%) | 12.4 ± 3.4 | 12.5 ± 3.4 | 12.4 ± 3.4 | 0.501 |
| Smoking status | 0.354 | |||
| Never smoker | 1411 (44.7%) | 651 (45.4%) | 760 (44.1%) | |
| Ex-smoker | 1043 (33.1%) | 455 (31.8%) | 588 (34.1%) | |
| Current smoker | 701 (22.2%) | 327 (22.8%) | 374 (21.7%) | |
| Packyears (years) | 19.5 (28.3) | 17.0 (26.0) | 21.0 (29.4) | <0.001 |
| ETS | 1099 (34.8%) | 541 (37.8%) | 558 (32.4%) | 0.002 |
| Regular physical activity | 1379 (43.7%) | 606 (42.3%) | 773 (44.9%) | 0.153 |
| BMI (kg/m2) | 27.6 ± 4.3 | 27.2 ± 4.4 | 28.0 ± 4.2 | <0.001 |
| LDL (mg/dl) | 146.3 ± 35.7 | 141.3 ± 34.4 | 150.5 ± 36.2 | <0.001 |
| HDL (mg/dl) | 59.3 ± 17.3 | 60.1 ± 17.4 | 58.6 ± 17.2 | 0.014 |
| Alcohol consumption | 0.049 | |||
| Never | 1519 (48.1%) | 683 (47.7%) | 836 (48.5%) | |
| 1–3 drinks/week | 490 (15.5%) | 246 (17.2%) | 244 (14.2%) | |
| >3–6 drinks/week | 348 (11%) | 166 (11.6%) | 182 (10.6%) | |
| >6–14 drinks/week | 412 (13.1%) | 182 (12.7%) | 230 (13.4%) | |
| >14 drinks/week | 386 (12.2%) | 156 (10.9%) | 230 (13.4%) | |
| Intake of statins at baseline[ | 213 (7.2%) | 59 (4.5%) | 154 (9.3%) | <0.001 |
| Incident statin use[ | 348 (11.8%) | 114 (8.7%) | 234 (14.2%) | <0.001 |
| Incident lipid-lowering meds[ | 375 (12.7%) | 131 (10.0%) | 244 (14.8%) | <0.001 |
| Framingham risk[ | <0.001 | |||
| Low | 1713 (54.6%) | 931 (65.5%) | 782 (45.7%) | |
| Medium | 1014 (32.3%) | 392 (27.6%) | 622 (36.3%) | |
| High | 408 (13%) | 99 (7.0%) | 309 (18.0%) | |
| Prevalent hypertension[ | 1677 (53.2%) | 631 (44.1%) | 1046 (60.7%) | <0.001 |
| Incident hypertension[ | 524 (35.5%) | 241 (30.1%) | 283 (41.9%) | <0.001 |
| Type 2 diabetes | 364 (11.5%) | 125 (8.7%) | 239 (13.9%) | <0.001 |
| Incident type 2 diabetes | 240 (8.6%) | 103 (7.9%) | 137 (9.2%) | 0.225 |
| Incident CAD[ | 99 (3.1%) | 25 (1.7%) | 74 (4.3%) | <0.001 |
t-test: Wilcoxon test or χ[2] independence test.
Median (interquartile range).
Additional missing observations.
Summary statistics and Pearson correlation coefficients for traffic-related long-term exposures for 3155 participants of the Heinz Nixdorf Recall Study.
| Exposure | Mean ± SD | IQR | PM2.5 | PNacc | NO2 | Lden | Lnight |
|---|---|---|---|---|---|---|---|
| PM10 (µg/m3)a | 20.2 ± 2.6 | 3.8 | 0.81 | 0.76 | 0.57 | 0.21 | 0.23 |
| PM2.5 (µg/m3)b | 16.7 ± 1.2 | 2.0 | 0.69 | 0.69 | 0.10 | 0.14 | |
| PNacc (#/mL)c | 3399 ± 382 | 520 | 0.69 | 0.20 | 0.21 | ||
| NO2 (µg/m3)d | 39.4 ± 4.0 | 5.3 | 0.18 | 0.21 | |||
| Lden (dB(A))e | 53.9 ± 9.3 | 14.4 | 0.99 | ||||
| Lnight (dB(A))f | 45.0 ± 9.1 | 13.7 | 1.00 |
PMx: particulate matter with an aerodynamic diameter < x µm; PNacc: particle number of accumulation mode particles; NO2: nitrogen dioxide; Lden: day-evening-night noise; Lnight: night-time noise; IQR: interquartile range. aPM10: particulate matter with an aerodynamic diameter <10 µm. bPM2.5: particulate matter with an aerodynamic diameter < 2.5 µm. cPNacc: particle number of accumulation mode particles. dNO2: nitrogen dioxide eLden: day-evening-night noise. fLnight: night-time noise; IQR: interquartile range.
Figure 1.Crude and main effect estimates (95% confidence interval) per interquartile range (IQR) exposure increase on thoracic aortic calcification (TAC) progression in the Heinz Nixdorf Recall study sample and stratified by TACt0, adjusted for age, sex, smoking, physical activity, alcohol consumption, education and follow-up years. (a) Odds ratios (ORs) for TAC progression; (b) change of TAC growth rate. Complementing numbers are presented in Supplementary Tables 1 and 2.
Figure 2.Effect estimates (95% confidence intervals) per interquartile range (IQR) exposure increase on thoracic aortic calcification (TAC) progression in participants with TACt0 < 10: co-exposure adjustment (dark grey) and effect modification (black). (a) TAC progression; (b) change of TAC growth rate. Models are adjusted for age, sex, smoking, alcohol consumption, physical activity, education and follow-up time. Complementing numbers are presented in Supplementary Table 7.